Molina Healthcare Reports $38 Million Net Income in Q3 2026, Membership Declines

Molina Healthcare, Inc. reported a net income of $38 million, or $0.73 per diluted share, for the third quarter of 2026, a significant decline from the $79 million, or $1.51 per diluted share, recorded in the same period last year. For the nine months ending September 30, 2026, net income totaled $112 million, down from $632 million in the prior year. The company's total revenue for the third quarter was $11.1 billion, a decrease of 3.4% from $11.5 billion in the third quarter of 2025, primarily driven by a reduction in premium revenue, which fell to $10.5 billion from $10.8 billion year-over-year.

The decline in financial performance is attributed to a 14% decrease in membership, which fell to approximately 4.9 million members as of September 30, 2026, compared to 5.6 million members a year earlier. This reduction was largely due to a general contraction in the Medicaid market and a strategic shift in the company's product offerings and pricing strategies. The consolidated medical care ratio (MCR) increased to 92.9% from 92.6% in the previous year, reflecting ongoing challenges in managing medical costs.

In terms of operational developments, Molina Healthcare has been actively pursuing strategic contracts to expand its footprint. The company recently secured a contract to provide Medicaid managed services in Florida, expected to serve around 120,000 enrollees, and has also been awarded contracts in Wisconsin and Illinois for Medicaid services. These contracts are part of Molina's broader strategy to enhance its market presence and improve profitability in the face of declining membership.

The company’s total assets increased slightly to $15.7 billion as of September 30, 2026, compared to $15.6 billion at the end of 2025. Cash and cash equivalents rose to $4.5 billion, up from $4.2 billion, while total liabilities remained stable at approximately $11.5 billion. Molina's employee headcount was consistent with previous periods, reflecting a stable operational structure despite the fluctuations in membership and revenue.

Looking ahead, Molina Healthcare anticipates continued challenges in the Medicaid and Marketplace segments, with expectations of further declines in membership and premium revenue. The company is focusing on improving margins through strategic exits from less profitable product lines, such as the Medicare Advantage-Prescription Drug (MAPD) product, and enhancing operational efficiencies. The outlook remains cautious as the company navigates regulatory changes and market dynamics that could impact future performance.